Increased peripheral platelet destruction and caspase-3– independent programmed cell death of bone marrow megakaryocytes in myelodysplastic patients by.

Slides:

Advertisements

Similar presentations

A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in.

Advertisements

High incidence of antibodies to protamine and protamine/heparin complexes in patients undergoing cardiopulmonary bypass by Grace M. Lee, Ian J. Welsby,

Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome by Bart.

Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome by Jacob H. Rand,

The angiogenesis inhibitor vasostatin is regulated by neutrophil elastase–dependent cleavage of calreticulin in AML patients by Sarah Mans, Yara Banz,

Combination immunosuppressant therapy for patients with chronic refractory immune thrombocytopenic purpura by Donald M. Arnold, Ishac Nazi, Aurelio Santos,

Platelet activation and inhibition in polycythemia vera and essential thrombocythemia by Carlo Patrono, Bianca Rocca, and Valerio De Stefano Blood Volume.

Lentiviral shRNA silencing of murine bone marrow cell CCR2 leads to persistent knockdown of CCR2 function in vivo by Ilze Bot, Jian Guo, Miranda Van Eck,

Generating AML-Specific Peripheral Blood Autologous Cytotoxic T-Lymphocytes (CTLs)‏ by Rohtesh S. Mehta, Xiaohua Chen, Antony Jeyaraj, and Paul Szabolcs.

Reconstructing the human hematopoietic niche in immunodeficient mice: opportunities for studying primary multiple myeloma by Richard W. J. Groen, Willy.

Determination of acute lung injury after repeated platelet transfusions by Laurence Corash, Jin Sying Lin, Claire D. Sherman, and Joseph Eiden Blood Volume.

Donor versus no-donor comparison of newly diagnosed myeloma patients included in the HOVON-50 multiple myeloma study by Henk M. Lokhorst, Bronno van der.

F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis by Samantha C. Gouw, H. Marijke.

Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene by A.

Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study.

A Randomized Trial Of Daily Prednisone Versus Pulsed Dexamethasone In Treatment Naïve Patients With Idiopathic Thrombocytopenic Purpura by Johannes Matschke,

by Toru Takahashi, Toshiaki Yujiri, and Yukio Tanizawa

by Henrik Frederiksen, and Kai Schmidt

Platelet Antibody Testing in Idiopathic Thrombocytopenic Purpura

Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival by Kai-Da Wu, Lisa.

In utero transplantation may soon be in delivery

Reduced tumor load in peripheral blood after treatment with G-CSF and chemotherapy in children with tumors of the Ewing sarcoma family but not neuroblastoma.

A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.

Successful Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplant in an Acute Leukemia Patient With Chemotherapy-Induced Marrow Aplasia and Progressive.

The V410I (G1228A) variant of the caspase-10 gene is a common polymorphism in the Danish population by Kirsten Grønbæk, Tine Dalby, Jesper Zeuthen, Elisabeth.

How I treat elderly patients with myeloma

Rapid Identification Of Compound Mutations In Patients With Ph-Positive Leukemias By Long-Range Next Generation Sequencing by Sandra Preuner, Renate Kastner,

Elevated Plasma Von Willebrand Factor and Decreased ADAMTS13 Antigen Levels in Patients with Immune Thrombocytopenia (ITP)‏ by Charlotte Louise Godfrey,

An Interim Analysis Of a Phase 2, Single-Arm Study Of Platelet Responses and Remission Rates In Patients With Immune Thrombocytopenia (ITP) Receiving Romiplostim.

Nonmyeloablative conditioning for relapsed follicular lymphoma

Irreversible myelosuppression after fludarabine-melphalan conditioning: observations in patients with graft rejection by Koen Van Besien, Sonali Smith,

Mechanisms of HIV-associated lymphocyte apoptosis

Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program by Michael.

by Karthik A. Ganapathi, Danielle M. Townsley, Amy P. Hsu, Diane C

Full hematopoietic engraftment after allogeneic bone marrow transplantation without cytoreduction in a child with severe combined immunodeficiency by Ronald.

Detection of Trisomy 12 and Rb-Deletion in CD34+ Cells of Patients With B-Cell Chronic Lymphocytic Leukemia by B. Gahn, C. Schäfer, J. Neef, C. Troff,

Relative increase in leukemia-specific DNA in peripheral blood plasma from patients with acute myeloid leukemia and myelodysplasia by Anna Rogers, Youngson.

Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development.

by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle

by Robert McMillan, Jennifer Lopez-Dee, and Joseph C. Loftus

Accurate quantification of minimal residual disease at day 15, by real-time quantitative polymerase chain reaction identifies also patients with B-precursor.

Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative.

ROCK and Rho(ll) in bone marrow

by Ineke J. M. ten Berge, and René A. W. van Lier

Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study by Samantha C. Gouw,

Does Helicobater pylori initiate or perpetuate immune thrombocytopenic purpura? by Marc Michel, Nichola Cooper, Christelle Jean, Christine Frissora, and.

Consensus strategy to quantitate malignant cells in myeloma patients is validated in a multicenter study by Peter Willems, Onno Verhagen, Christine Segeren,

In vitro migratory capacity of CD34+ cells is related to hematopoietic recovery after autologous stem cell transplantation by Carlijn Voermans, Marisha.

Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal.

by Martin S. Tallman, Donna Neuberg, John M. Bennett, Christopher J

Long-term acquisition of allergen-specific IgE and asthma following allogeneic bone marrow transplantation from allergic donors by Teal S. Hallstrand,

Aging Impairs Long-Term Hematopoietic Regeneration after Autologous Stem Cell Transplantation Carolien M. Woolthuis, Niccoló Mariani, Rikst Nynke Verkaik-Schakel,

Platelet transfusions improve hemostasis and survival in a substudy of the prospective, randomized PROPPR trial by Jessica C. Cardenas, Xu Zhang, Erin.

by Geling Li, Emily Waite, and Julie Wolfson

by Fumiko Chino, Arif H. Kamal, Junzo Chino, and Thomas W. LeBlanc

Systemic inflammation induces release of cell-free DNA from hematopoietic and parenchymal cells in mice and humans by Anne Jan van der Meer, Anna Kroeze,

Immunoblots of PLCβ isoforms in wild-type and PLCβ2/β3-null platelets.

Hematopoietic potential of HEP from patient-specific iPSC may be reduced. Hematopoietic potential of HEP from patient-specific iPSC may be reduced. (A)

Erratum in Ledru et al. Alteration of tumor necrosis factor–α T-cell homeostasis following potent antiretroviral therapy: contribution to the development.

Pain. Pain. (A) Skeletal pain experienced by bone marrow (BM) and peripheral blood stem cell (PBSC) donors at baseline, during the pericollection period,

Schematic model of the mechanism of Tak1 protection of HSPC survival.

Leukemic blasts express a “hypoxia signature

Mary Eapen Biology of Blood and Marrow Transplantation

Mesenchymal Stem Cell-Derived Vesicles Reverse Hematopoietic Radiation Damage by Sicheng Wen, Laura R Goldberg, Mark S Dooner, John L Reagan, and Peter.

Representative staining of bone marrow aspirates collected from a patient at baseline and after 1 cycle of treatment with 45 mg/m2 selinexor + 20 mg dexamethasone,

A binding relationship with thrombin

Pure red cell aplasia by Robert T. Means Blood

Patient Tregs express normal levels of suppression.

MDSC population in patient peripheral blood.

Cold agglutinin disease

Presentation transcript:

Increased peripheral platelet destruction and caspase-3– independent programmed cell death of bone marrow megakaryocytes in myelodysplastic patients by Ewout J. Houwerzijl, Nel R. Blom, Johannes J. L. van der Want, Henk Louwes, Mariet T. Esselink, Jan W. Smit, Edo Vellenga, and Joost Th. M. de Wolf Blood Volume 105(9): May 1, 2005 ©2005 by American Society of Hematology

Correlation between the glycocalicin (GC) index and the platelet production rate (PPR). Ewout J. Houwerzijl et al. Blood 2005;105: ©2005 by American Society of Hematology

Ultrastructure of megakaryocytes from a healthy bone marrow donor and an MDS patient. Ewout J. Houwerzijl et al. Blood 2005;105: ©2005 by American Society of Hematology

Correlation between the percentage of MDS megakaryocytes in programmed cell death (PCD) and the number of platelets. Ewout J. Houwerzijl et al. Blood 2005;105: ©2005 by American Society of Hematology

Immunohistochemical detection of activated caspase-3 in megakaryocytes from a healthy donor, and MDS and ITP patients. Ewout J. Houwerzijl et al. Blood 2005;105: ©2005 by American Society of Hematology

Activated caspase-8 in megakaryocytes from a healthy donor and MDS patients. Ewout J. Houwerzijl et al. Blood 2005;105: ©2005 by American Society of Hematology